Healthcare Opinion
Doctors and pharmacists share their experience with biosimilar medicines
We’ve talked to healthcare professionals from across the country to bring you their thoughts on biosimilar medicines.
Hear From Rheumatologists
Prof Paul Bird and A/Prof Andrew Östör
Hear From Gastroenterologists
Dr Simon Ghaly and Dr Lena Thin
Hear From Oncologists
Prof Stephen Clarke and Prof John Zalcberg
Hear From a Haematologist
Prof Jeff Szer
Hear From Pharmacists
Barry Jenkins and David Ford
Biosimilar medicines in Australia
Rheumatologist Prof Michelle Leech answers your questions
Biosimilar medicines in Australia
Diabetes specialist Prof Steven Boyages answers your questions
Biosimilar medicines in Australia
Gastroenterologist Prof Craig Haifer answers your questions
Biosimilar medicines in Australia
Oncologist Prof Stephen Clarke answers your questions
Hear From Rheumatologists
Prof Paul Bird and A/Prof Andrew Östör
Hear From Gastroenterologists
Dr Simon Ghaly and Dr Lena Thin
Hear From Oncologists
Prof Stephen Clarke and Prof John Zalcberg
Hear From a Haematologist
Prof Jeff Szer
Hear From Pharmacists
Barry Jenkins and David Ford
Biosimilar medicines in Australia
Rheumatologist Prof Michelle Leech answers your questions
Biosimilar medicines in Australia
Diabetes specialist Prof Steven Boyages answers your questions
Biosimilar medicines in Australia
Gastroenterologist Prof Craig Haifer answers your questions